Sign inJoin waitlistJoin the waitlist

Nathan Shapiro

Vice-Chair, Research, Department of Emergency Medicine, BIDMC · Beth Israel Deaconess Medical Center

Credentials: · · · ·

History

Research · Beth Israel Deaconess Medical Center
Present
BIDMC · Beth Israel Deaconess Medical Center
Present
Beth Israel Deaconess Medical Center
Present

Emergency Medicine
Mass General Brigham
1996–2000
Temple University School of Medicine
1992–1996

Research

A randomized trial of protocol-based care for early septic shock
New England Journal of Medicine · 2014 · 1,818 citations
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
Critical Care · 2013 · 1,010 citations
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020
MMWR Morbidity and Mortality Weekly Report · 2020 · 884 citations

Wesley Self
88 papers
Adit Ginde
70 papers
Kevin Gibbs
60 papers
Jay Steingrub
57 papers
Akram Khan
55 papers
Matthew Exline
55 papers
Todd Rice
55 papers
Ithan Peltan
50 papers
Jonathan Casey
50 papers · 39 as a fellow
Michelle Gong
50 papers
Samuel Brown
49 papers
David Hager
48 papers

Grants

Genetically Linked Metabolites of Sepsis Severity and Mortality
National Heart, Lung, and Blood Institute · R21
PI · $256.8K · University of Michigan at Ann Arbor
2025–2027
Optimization of a Rapid Assay to Quantify Circulating Glycosaminoglycans and Identify Vascular Endotypes of Sepsis
National Institute of General Medical Sciences · R33
PI · $1.3M · Massachusetts General Hospital
2023–2027
Optimizing Methods of Clinical Sample Processing for scRNA-Seq and Mechanistic Studies in Sepsis to Enable Reliable, Reproducible, and High-Yield Multi-Center Collection Efforts
National Institute of General Medical Sciences · R33
PI · $1.3M · Massachusetts General Hospital
2023–2026
Optimization of a Rapid Assay to Quantify Circulating Glycosaminoglycans and Identify Vascular Endotypes of Sepsis
National Institute of General Medical Sciences · R21
PI · $479.8K · Massachusetts General Hospital
2023–2025

Clinical trials

FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test
Principal investigator · Completed
Rapid Pathogen Screening
2019–2021
Ischemic Conditioning in STEMI Patients
Principal investigator · Completed
Beth Israel Deaconess Medical Center
2012–2021
Non-Invasive Shock: Differentiating Shock in the Emergency Department
Principal investigator · Completed
Beth Israel Deaconess Medical Center
2012–2020
Procalcitonin Monitoring Sepsis Study
Principal investigator · Completed
Brahms AG
2011–2014